AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From CBS Marketwatch (Stories))
NEW YORK (CBS.MW) -- Shares of Syneron Medical Ltd. skidded 28 percent Tuesday after the Food and Drug Administration refused to let the company market its VelaSmooth system in the United States with a 510(k) pre-market notification.
Rather, the FDA requested late Monday that Syneron , which specializes in medical aesthetic devices, resubmit VelaSmooth with a pre-market approval application.
With a pair of analysts downgrading the shares after the news, Syneron closed down $10.49, or 28 percent, at $26.71 after touching a session low of $26.57.
VelaSmooth has already been cleared for the non-invasive…